Venture capital firm

Archangel Investors Limited

Scottish early-stage investor backing disruptive technology companies with protectable intellectual property

Visit Website Get introducedRequest an introduction Write a Review

TrustList summary

Archangel Investors Limited, known as Archangels, is an investor in early-stage businesses in Scotland. It has been investing in innovation for thirty years.

Products and services

Early-stage investment: funding for young companies that are growing.
Technology focus: disruptive technology with protectable intellectual property that rivals find hard to copy.
Board involvement: its news mentions founders joining its board.
Portfolio access: a public list of the companies it has backed.

Who it works with

Early-stage Scottish businesses. Its recent news covers Blackford Analysis, later acquired by Bayer, Hearing Diagnostics, MatchPoint Hospitality, PhysioMedics and Cytomos.

Key facts

Region: Scotland
Track record: thirty years of investing

Summary written by TrustList from the business's own published information, Oct 2026.

Gallery

2 images - click to enlarge

Categories & features

Rankings

Archangel Investors Limited is ranked on 2 TrustList rankings: #2 on 1 and #7 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Archangel Investors Limited has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 2 rankings

#2of 9
Edinburgh
It is one of 2 here listing biotech.
Of the 9 here, 2 also cover climate tech and 2 also cover biotech; 5 also work in London and 2 also work in Manchester.
Behind Invest Northern Ireland, ahead of Foresight Group (investor).
#7of 79
Biotech investors
Of the top 65 here, 22 also cover healthtech and 17 also cover science; 14 also work in Boston and 13 also work in San Francisco.
Behind TVM Capital, ahead of LSP BioVentures.